These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9247834)

  • 1. Controlling varicella in the healthcare setting: the cost effectiveness of using varicella vaccine in healthcare workers.
    Nettleman MD; Schmid M
    Infect Control Hosp Epidemiol; 1997 Jul; 18(7):504-8. PubMed ID: 9247834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of varicella vaccination of healthcare workers.
    Chodick G; Ashkenazi S; Livni G; Lerman Y
    Vaccine; 2005 Oct; 23(43):5064-72. PubMed ID: 16046036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of varicella vaccination for health care workers.
    Gray AM; Fenn P; Weinberg J; Miller E; McGuire A
    Epidemiol Infect; 1997 Oct; 119(2):209-20. PubMed ID: 9363019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule.
    Scuffham P; Devlin N; Eberhart-Phillips J; Wilson-Salt R
    Soc Sci Med; 1999 Sep; 49(6):763-79. PubMed ID: 10459888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella vaccination for healthcare workers at a university hospital: an analysis of costs and benefits.
    Tennenberg AM; Brassard JE; Van Lieu J; Drusin LM
    Infect Control Hosp Epidemiol; 1997 Jun; 18(6):405-11. PubMed ID: 9181396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.
    Hanslik T; Boëlle PY; Schwarzinger M; Carrat F; Freedberg KA; Valleron AJ; Flahault A
    Vaccine; 2003 Sep; 21(25-26):3614-22. PubMed ID: 12922090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of vaccination strategies in adults without a history of chickenpox.
    Smith KJ; Roberts MS
    Am J Med; 2000 Jun; 108(9):723-9. PubMed ID: 10924649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives.
    Hsu HC; Lin RS; Tung TH; Chen TH
    Vaccine; 2003 Sep; 21(25-26):3982-7. PubMed ID: 12922134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a routine varicella vaccination program for US children.
    Lieu TA; Cochi SL; Black SB; Halloran ME; Shinefield HR; Holmes SJ; Wharton M; Washington AE
    JAMA; 1994 Feb; 271(5):375-81. PubMed ID: 8283587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella vaccine, cost-effectiveness analyses, and vaccination policy.
    Davis MM
    JAMA; 2005 Aug; 294(7):845-6. PubMed ID: 16106012
    [No Abstract]   [Full Text] [Related]  

  • 11. Varicella vaccination in Italy : an economic evaluation of different scenarios.
    Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
    Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling varicella in the healthcare setting: barriers to varicella vaccination among healthcare workers.
    Qureshi M; Gordon SM; Yen-Lieberman B; Litaker DG
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):516-8. PubMed ID: 10432167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic value of childhood varicella vaccination in France and Germany.
    Coudeville L; Brunot A; Szucs TD; Dervaux B
    Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
    Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation.
    Olson AD; Shope TC; Flynn JT
    Pediatr Transplant; 2001 Feb; 5(1):44-50. PubMed ID: 11260488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of varicella vaccination programs: an update of the literature.
    Rozenbaum MH; van Hoek AJ; Vegter S; Postma MJ
    Expert Rev Vaccines; 2008 Aug; 7(6):753-82. PubMed ID: 18665775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cost-benefit analysis of a routine varicella vaccination program for United States Air Force Academy cadets.
    Burnham BR; Wells TS; Riddle JR
    Mil Med; 1998 Sep; 163(9):631-4. PubMed ID: 9753992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of routine childhood varicella vaccination in Germany.
    Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
    Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of varicella vaccine programs for Australia.
    Scuffham PA; Lowin AV; Burgess MA
    Vaccine; 1999 Oct; 18(5-6):407-15. PubMed ID: 10519929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should health care workers in the tropics be immunized against varicella?
    Richard VS; John TJ; Kenneth J; Ramaprabha P; Kuruvilla PJ; Chandy GM
    J Hosp Infect; 2001 Mar; 47(3):243-5. PubMed ID: 11247687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.